Kerstin M Gustafsson Selected Research

plasmin-plasmin inhibitor complex

1/2022

Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kerstin M Gustafsson Research Topics

Disease

2	Coronary Disease (Coronary Heart Disease) 05/2021 - 08/2015
2	Myocardial Infarction 05/2021 - 01/2019
2	Activated Protein C Resistance (APC Resistance) 11/2018 - 02/2011
1	COVID-19 01/2022
1	Acute Coronary Syndrome 08/2015
1	ST Elevation Myocardial Infarction 08/2015
1	Thrombosis (Thrombus) 08/2015
1	Hemorrhage 03/2015

Drug/Important Bio-Agent (IBA)

3	AntithrombinsIBA 01/2022 - 02/2011
2	Clopidogrel (Plavix)FDA Link 01/2019 - 08/2015
2	Dabigatran FDA Link 03/2015 - 02/2011
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	plasmin-plasmin inhibitor complexIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 11/2018
1	Abciximab (ReoPro)FDA Link 08/2015
1	Indicators and Reagents (Reagents)IBA 02/2011
1	factor V LeidenIBA 02/2011
1	Thromboplastin (Tissue Factor)IBA 02/2011
1	Fibrinogen (Factor I)FDA Link 02/2011

Therapy/Procedure

2	Therapeutics 05/2021 - 01/2019
1	Stents 08/2015